Found 1769 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
C. S. Wong, Ho, P. L., Stablein, D. M., Alexander, S., Warady, B., Tejani, A., and Watkins, S. L., Risk Factors for Anemia During Erythropoietin Therapy Among Pediatric Dialysis Patients: A North American Pediatric Cooperative Study (NAPRTCS) Report, in ASN, Toronto, Canada, 2001.
Y. J. Wong, Keenan, J., Hudson, K., Bryan, H., Naftolin, F., Thompson, V. P., Craig, R. G., Vena, D., Collie, D., Wu, H., Matthews, A. G., Grill, A. C., and Curro, F. A., Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings, Compend Contin Educ Dent, vol. 37, no. 10, pp. 710-718, 2016.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
M. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santo, S. M., A Case-Control-Study of Risk Factors for Homophiles Influenza Type B Disease in Navajo Children, AM J Trop Med Hug, vol. 60, no. 2, pp. 263-266, 1999.
U. E. K. Wolf-Schnurrbusch, Leung, I., Sallo, F. B., Clemons, T. E., Chew, E. Y., Bird, A. C., and Peto, T., Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia., Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
J. S. Wittenborn, Clemons, T. E., Regillo, C., Rayess, N., D Kruger, L., and Rein, D., Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System, JAMA Ophthalmol, 2017.
P. L. Winokur, Chaloner, K., Doem, G. V., Ferreira, J., and Apicella, M. A., Safety and Immunological Outcomes Following Human Inoculation with Nontypeable Haemophilus Influenzae, J Infect Dis, vol. 208, pp. 728-738, 2013.
P. L. Winokur, Patel, S. M., Brady, R., Chen, W. H., El-Kamary, S. S., Edwards, K., Creech, C. B., Frey, S., Keitel, W. A., Belshe, R., Walter, E., Bellamy, A., and Hill, H., Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine, J Infect Dis, vol. 212, no. 4, pp. 525-530, 2015.
T. M. Winhusen, Stitzer, M. L., Woody, G. E., Brigham, G. S., Kropp, F. B., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals, Contemp Clin Trials, vol. 33, pp. 197-205, 2012.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
T. Winhusen, Lewis, D., Sharma, G., and Sparenborg, S., A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., Van Veldhuisen, P., Theobald, J., May, J., and Brigham, G. S., Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
J. Wingard, Carter, S., Walsh, T., Kurtzberg, J., Small, T., Baden, L., Gersten, I., Mendizabal, A., Leather, H., Confer, D., Maziarz, R., Stadtmauer, E., Bolanos-Meade, J., Brown, J., DiPersio, J., Boeckh, M., and Marr, K., Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation, Blood, vol. 116, pp. 5111-5118, 2010.
S. H. Wilson, Weaver, L. K., and Lindblad, A. S., Neuropsychological Assessments in a Hyperbaric Trial of Post-Concussive Symptoms, Undersea Hyperb Med, vol. 43, no. 5, pp. 585-599, 2016.
R. F. Willkens, Sharp, J. T., Stablein, D., Marks, C., and Wortmann, R., Comparison of Azathioprine, Methotrexate, and the Combination of the Two in the Treatment of Rheumatoid Arthritis. A Forty-Eight-Week Controlled Clinical Trial With Radiologic Outcome Assessment., Arthritis Rheum, vol. 38, no. 12, pp. 1799-1806, 1995.
A. D. Williams, Grantz, K. L., Zhang, C., Nobles, C., Sherman, S., and Mendola, P., Ambient volatile organic compounds and racial/ethnic disparities in gestational diabetes mellitus: Are Asian/Pacific Islander women at greater risk?, Am J Epidemiol, 2018.
C. Williams, Weaver, L. K., Langford, D., Lindblad, A., and Wierzbicki, M. R., Neurological Evaluations within the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA), in Undersea and Hyperbaric Medical Society Annual Scientific Meeting; Military Health System Research Symposium, 2014.
S. D. Williams, Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., and Spaulding, J. T., Immediate Adjuvant Chemotherapy Versus Observation with Treatment at Relapse in Pathological Stage II Testicular Cancer, N Engl J Med, vol. 317, no. 23, pp. 1433-1438, 1987.
H. E. Wiley, Thompson, D. J. S., Bailey, C., Chew, E. Y., Cukras, C. A., Jaffe, G. J., Lee, R. W. J., Loken, E. K., Meyerle, C. B., Wong, W., and Ferris, F. L. 3rd, A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema, Ophthalmology, vol. 123, no. 4, p. 841, 2016.
H. Wiley, Bailey, C., Cukras, C., Jaffe, G., Lee, R., Loken, E., Meyerle, C., Thompson, D., Wong, W., and Ferris, F., A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema, in 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., Allingham, R. R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., Van Veldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., Common Variants at 9p21 and 8q22 are Associated with Increased Susceptibility to Optic Nerve Degeneration in Glaucoma, PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
L. E. Widdice, Unger, E. R., Panicker, G., Hoagland, R., S Callahan, T., Jackson, L. A., Berry, A. A., Kotloff, K., Frey, S. E., Harrison, C. J., Pahud, B. A., Edwards, K. M., Mulligan, M. J., Sudman, J., and Bernstein, D. I., Antibody Responses Among Adolescent Females Receiving Two or Three Quadrivalent Human Papillomavirus Vaccine Doses at Standard and Prolonged Intervals, Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
L. E. Widdice, Hoagland, R., S Callahan, T., Kahn, J. A., Harrison, C. J., Pahud, B. A., Frey, S. E., Berry, A. A., Kotloff, K. L., Edwards, K. M., Mulligan, M. J., Sudman, J., Nakamura, A., and Bernstein, D. I., Caregiver and Adolescent Factors Associated with Delayed Completion of the Three-Dose Human Papillomavirus Vaccination Series, Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
T. Whiteside, Griffin, D., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., Shipping of Therapeutic Somatic Cell Products, Cytotherapy, vol. 13, pp. 201-213, 2011.
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A., Discontinuation of Anticytomegalovirus Therapy in Patients with HIV Infection and Cytomegalovirus Retinitis, JAMA, vol. 282, no. 17, pp. 1633-1637, 1999.